This inventor holds 58 USPTO granted patents and 47 published patent applications and 8 EPO patents, primarily in Immune Modulation. Top assignees: Massachusetts Institute of Technology, The Broad Institute, Inc., The Brigham and Women's Hospital, Inc.. Active years: 2006-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
53 out of 8,594 
51 out of 488 
17 out of 1,429 
Years Active: 2006-2026
Areas of Expertise:
Title: Aviv Regev: Pioneering Innovations in Genomics and Computational Biology
Introduction:
Aviv Regev, an esteemed inventor based in Cambridge, MA, is renowned for his groundbreaking work in genomics and computational biology. His unwavering commitment to innovation and scientific excellence has positioned him as a trailblazer in the field, inspiring future generations of inventors and researchers.
Latest Patents:
Aviv Regev's latest patents showcase his dedication to advancing cancer research and evolutionary biology. One of his notable patents includes "Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer," which focuses on predicting overall survival in cancer and developing targeted therapeutics. Another patent highlights a "High-throughput dynamic reagent delivery system," aimed at creating complex environments to enhance evolution in cell populations and gain insights into drug resistance during cancer chemotherapy.
Career Highlights:
Throughout his illustrious career, Aviv Regev has made significant contributions to the scientific community. He has been instrumental in revolutionizing biotechnology through his work at prestigious institutions such as the Massachusetts Institute of Technology and The Broad Institute, Inc. His innovative research has led to 29 patents, showcasing his expertise and impact in the field.
Collaborations:
Aviv Regev has collaborated with esteemed colleagues such as Jellert Gaublomme and Vijay K Kuchroo, further expanding the scope of his research and fostering a culture of collaboration in the scientific community. These collaborations have enabled him to drive forward pioneering projects and achieve remarkable milestones in genomics and computational biology.
Conclusion:
In conclusion, Aviv Regev's passion for innovation and relentless pursuit of scientific excellence have cemented his status as a leading figure in genomics and computational biology. His groundbreaking patents, illustrious career, and fruitful collaborations underscore his enduring impact on the field, inspiring continued advancements and breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile